Literature DB >> 12213445

Abnormal phosphorylation of synapsin I predicts a neuronal transmission impairment in the R6/2 Huntington's disease transgenic mice.

Jean-Charles Liévens1, Benjamin Woodman, Amarbirpal Mahal, Gillian P Bates.   

Abstract

Motor and cognitive deficits in Huntington's disease (HD) are likely caused by progressive neuronal dysfunction preceding neuronal cell death. Synapsin I is one of the major phosphoproteins regulating neurotransmitter release. We report here an abnormal phosphorylation state of synapsin I in the striatum and the cerebral cortex of R6/2 transgenic mice expressing the HD mutation. These changes are mostly characterized by an early overphosphorylation at sites 3-5, whereas phosphorylation at site 1 remains unchanged and at site 6 becomes reduced only close to the end stage of the disease. Such changes do not result from modification in protein expression levels. However, we show a decreased expression of the calcineurin regulatory subunit-B, which may contribute to an imbalance between kinase and phosphatase activities. Together the results suggest that an early impairment in synapsin phosphorylation-dephosphorylation may alter synaptic vesicle trafficking and lead to defective neurotransmission in HD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213445     DOI: 10.1006/mcne.2002.1152

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  21 in total

1.  Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity.

Authors:  Ana Saavedra; Albert Giralt; Laura Rué; Xavier Xifró; Jian Xu; Zaira Ortega; José J Lucas; Paul J Lombroso; Jordi Alberch; Esther Pérez-Navarro
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

Review 2.  The role of serine/threonine protein phosphatases in exocytosis.

Authors:  Alistair T R Sim; Monique L Baldwin; John A P Rostas; Jeff Holst; Russell I Ludowyke
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

Review 3.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

Review 4.  Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Authors:  Ying C Li; Ege T Kavalali
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 5.  Axonal transport defects in neurodegenerative diseases.

Authors:  Gerardo A Morfini; Matthew Burns; Lester I Binder; Nicholas M Kanaan; Nichole LaPointe; Daryl A Bosco; Robert H Brown; Hannah Brown; Ashutosh Tiwari; Lawrence Hayward; Julia Edgar; Klaus-Armin Nave; James Garberrn; Yuka Atagi; Yuyu Song; Gustavo Pigino; Scott T Brady
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

6.  CalDAG-GEFI down-regulation in the striatum as a neuroprotective change in Huntington's disease.

Authors:  Jill R Crittenden; Denise E Dunn; Farhan I Merali; Ben Woodman; Michael Yim; Anna E Borkowska; Matthew P Frosch; Gillian P Bates; David E Housman; Donald C Lo; Ann M Graybiel
Journal:  Hum Mol Genet       Date:  2010-02-10       Impact factor: 6.150

Review 7.  The Role of Synapsins in Neurological Disorders.

Authors:  Fatima Javed Mirza; Saadia Zahid
Journal:  Neurosci Bull       Date:  2017-12-27       Impact factor: 5.203

Review 8.  The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.

Authors:  Jia Yi Li; Natalija Popovic; Patrik Brundin
Journal:  NeuroRx       Date:  2005-07

9.  Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.

Authors:  Carlos Cepeda; Raymond S Hurst; Christopher R Calvert; Elizabeth Hernández-Echeagaray; Oanh K Nguyen; Emily Jocoy; Lindsey J Christian; Marjorie A Ariano; Michael S Levine
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

10.  Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.

Authors:  Damian M Cummings; Véronique M André; Besim O Uzgil; Steven M Gee; Yvette E Fisher; Carlos Cepeda; Michael S Levine
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.